These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 128813)

  • 81. Fibrinolysis in relation to body fatness, serum lipids and coronary heart disease in African and Asian men in Uganda.
    Shaper AG; Jones KW; Kyobe J; Jones M
    J Atheroscler Res; 1966; 6(4):313-27. PubMed ID: 5975280
    [No Abstract]   [Full Text] [Related]  

  • 82. The problem of intravascular fibrinolytic reaction.
    Fletcher AP
    Thromb Diath Haemorrh Suppl; 1967; 26():343-50. PubMed ID: 6064865
    [No Abstract]   [Full Text] [Related]  

  • 83. [Seasonal changes in the blood coagulating and anticoagulating system indices in men at the preclinical stage of ischemic heart disease].
    Andreenko GV; Panchenko VM; Liutova LV; Lisina AN; Karabasova MA
    Kardiologiia; 1980 Mar; 20(3):61-4. PubMed ID: 6103080
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Isolation and purification of antiplasmins from human granulocytes.
    Wolosowicz N; Prokopowicz J
    Thromb Diath Haemorrh; 1970 Dec; 24(3):543-7. PubMed ID: 4251261
    [No Abstract]   [Full Text] [Related]  

  • 85. Plasma fibrin-stabilizing factor: acquired deficiency in various disorders.
    Mandel EE; Gerhold WM
    Am J Clin Pathol; 1969 Nov; 52(5):547-56. PubMed ID: 5347067
    [No Abstract]   [Full Text] [Related]  

  • 86. Blood coagulation and fibrinolysis in multiple myeloma.
    Mohler ER; Kennedy JN; Brakman P
    Am J Med Sci; 1967 Mar; 253(3):325-32. PubMed ID: 4225585
    [No Abstract]   [Full Text] [Related]  

  • 87. Coagulation studies in cerebrovascular disease. II. Cooperative study of stroke patients in Minnesota and Japan (preliminary communication).
    Ettinger MG; Kusonoki R; Fujishima H
    Neurology; 1967 Aug; 17(8 Pt 1):797-801. PubMed ID: 15088541
    [No Abstract]   [Full Text] [Related]  

  • 88. Platelet hyperreactivity and inefficient spontaneous thrombolysis in patients at high risk from an acute coronary event.
    Peters NS; Abrams LS; Dymond DS; Kovacs IB
    Cardiovasc Res; 1989 Jul; 23(7):567-72. PubMed ID: 2598212
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Evidence against hypercoagulability in coronary artery disease.
    Görög P; Ridler CD; Rees GM; Kovacs IB
    Thromb Res; 1995 Aug; 79(4):377-85. PubMed ID: 7482441
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Coagulation defects and metastatic neuroblastoma.
    McMillan CW; Gaudry CL; Holemans R
    J Pediatr; 1968 Mar; 72(3):347-50. PubMed ID: 5639748
    [No Abstract]   [Full Text] [Related]  

  • 91. FIBRINOLYTIC EFFECT OF METFORMIN IN CORONARY-ARTERY DISEASE.
    CHAKRABARTI R; HOCKING ED; FEARNLEY GR
    Lancet; 1965 Aug; 2(7406):256-9. PubMed ID: 14330058
    [No Abstract]   [Full Text] [Related]  

  • 92. [Fibrinogen--interpretation of the test results].
    Yamada S; Izuchi Y; Miyanishi E; Kusunose K
    Nihon Rinsho; 1973; 31():1705-12. PubMed ID: 4582276
    [No Abstract]   [Full Text] [Related]  

  • 93. Effect of feeding fat on fibrinolysis, stypven time, and platelet aggregation in elderly Africans.
    Ferguson JC; Mackay N; McNicol GP
    J Clin Pathol; 1972 Jul; 25(7):574-6. PubMed ID: 5070254
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Hemostatic factors as triggers of cardiovascular events.
    Rosito GB; Tofler GH
    Cardiol Clin; 1996 May; 14(2):239-50. PubMed ID: 8724556
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Coagulation disorders in cancer. 3. Fibrinolysis and inhibitors.
    Soong BC; Miller SP
    Cancer; 1970 Apr; 25(4):867-74. PubMed ID: 4245659
    [No Abstract]   [Full Text] [Related]  

  • 96. [Change in certain indicators of a coagulogram depending on age].
    Pliutto AM
    Lab Delo; 1976; (1):51. PubMed ID: 56494
    [No Abstract]   [Full Text] [Related]  

  • 97. Cardiovascular disease in the tropics. IV. Coronary heart disease.
    Shaper AG
    Br Med J; 1972 Oct; 4(5831):32-5. PubMed ID: 4562279
    [No Abstract]   [Full Text] [Related]  

  • 98. Haemostatic factors in coronary heart disease.
    Nordøy A
    J Intern Med; 1993 May; 233(5):377-83. PubMed ID: 8487003
    [No Abstract]   [Full Text] [Related]  

  • 99. alpha2-Antiplasmin inhibitor deficiency.
    Collen D
    Lancet; 1979 May; 1(8124):1039-40. PubMed ID: 86764
    [No Abstract]   [Full Text] [Related]  

  • 100. [Significance of the test using local hypoxia in the evaluation of the reactive capacity of coagulation and anticoagulation systems of blood in patients with arteriosclerotic cardiosclerosis].
    Shpirt EIa
    Kardiologiia; 1973 Dec; 13(12):105-6. PubMed ID: 4778813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.